淋巴瘤的影像学检查：氟脱氧葡萄糖正电子发射断层扫描的关键作用
Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography.
作者信息
Meignan Michel, Hutchings Martin, Schwartz Lawrence H
机构信息
Centre Universitaire Hospitalier Henri Mondor, Lymphoma Study Association Imaging, Créteil, France; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Columbia University Medical Center, New York, New York, USA
Centre Universitaire Hospitalier Henri Mondor, Lymphoma Study Association Imaging, Créteil, France; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Columbia University Medical Center, New York, New York, USA.
出版信息
Oncologist. 2015 Aug;20(8):890-5. doi: 10.1634/theoncologist.2015-0036. Epub 2015 Jul 14.
Abstract
This review focuses on the impact of new imaging guidelines for fluorodeoxyglucose-positron emission tomography (FDG-PET) on clinical practice and the future directions of lymphoma imaging.
摘要
本综述重点关注氟脱氧葡萄糖正电子发射断层扫描（FDG-PET）新成像指南对临床实践的影响以及淋巴瘤成像的未来发展方向。
相似文献
1
Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography.
Oncologist. 2015 Aug;20(8):890-5. doi: 10.1634/theoncologist.2015-0036. Epub 2015 Jul 14.
2
The evolving role of fluorodeoxyglucose positron emission tomography (FDG PET) in lymphoma: how do we reconcile conflicting results in the era of evidence-based medicine?
Leuk Lymphoma. 2006 Oct;47(10):2008-10. doi: 10.1080/10428190600758611.
3
VI. FDG-PET as a biomarker in lymphoma: from qualitative to quantitative analysis.
Hematol Oncol. 2015 Jun;33 Suppl 1:38-41. doi: 10.1002/hon.2214.
4
Role of positron emission tomography in lymphoma.
J Clin Oncol. 2005 Jul 20;23(21):4577-80. doi: 10.1200/JCO.2005.01.904. Epub 2005 Apr 18.
5
When 18-fluorodeoxyglucose-positron emission tomography is indeterminate, the International Prognostic Index is the answer.
Leuk Lymphoma. 2010 Apr;51(4):569-70. doi: 10.3109/10428191003695686.
6
FDG PET/CT for assessing therapy response in primary thyroid lymphoma.
Clin Nucl Med. 2007 Feb;32(2):152-3. doi: 10.1097/01.rlu.0000252241.01390.be.
7
Machine Learning for Automated Interpretation of Fluorodeoxyglucose-Positron Emission Tomography Scans in Lymphoma.
J Clin Oncol. 2024 Sep 1;42(25):2945-2948. doi: 10.1200/JCO.24.00675. Epub 2024 Jun 21.
8
The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients.
Radiol Clin North Am. 2008 Mar;46(2):199-211, vii. doi: 10.1016/j.rcl.2008.03.004.
9
Solitary splenic lymphoma detected with (18)F-FDG-PET/CT.
Hell J Nucl Med. 2011 May-Aug;14(2):179-80.
10
FDG-PET interpretation in tonsillar lymphoma.
Acta Otolaryngol. 2007 Oct;127(10):1118-20. doi: 10.1080/00016480601127018.
引用本文的文献
1
18F-FDG PET or PET/CT in detecting high-grade transformation of chronic lymphocytic leukaemia and indolent lymphomas: a systematic review and meta-analysis.
Br J Radiol. 2025 May 1;98(1169):669-678. doi: 10.1093/bjr/tqaf028.
2
The Role of [F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.
Cancers (Basel). 2025 Jan 13;17(2):231. doi: 10.3390/cancers17020231.
3
Mantle Cell Lymphoma With Cardiac Involvement Presenting as Complete Heart Block.
JACC Case Rep. 2024 Aug 7;29(15):102416. doi: 10.1016/j.jaccas.2024.102416.
4
Overview of F18-FDG uptake patterns in retroperitoneal pathologies: imaging findings, pitfalls, and artifacts.
Abdom Radiol (NY). 2024 May;49(5):1677-1698. doi: 10.1007/s00261-023-04139-x. Epub 2024 Apr 23.
5
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma.
Blood Adv. 2023 Aug 22;7(16):4608-4618. doi: 10.1182/bloodadvances.2022009426.
6
The diagnostic performance of whole-body MRI in the staging of lymphomas in adult patients compared to PET/CT and enhanced reference standard-systematic review and meta-analysis.
Quant Imaging Med Surg. 2022 Feb;12(2):1558-1570. doi: 10.21037/qims-21-649.
7
Limited benefit of additional contrast-enhanced CT to end-of-treatment PET/CT evaluation in patients with follicular lymphoma.
Sci Rep. 2021 Sep 16;11(1):18496. doi: 10.1038/s41598-021-98081-x.
本文引用的文献
1
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies.
Lancet Haematol. 2014 Oct;1(1):e17-27. doi: 10.1016/S2352-3026(14)70008-0. Epub 2014 Sep 17.
2
FDG PET/CT imaging as a biomarker in lymphoma.
Eur J Nucl Med Mol Imaging. 2015 Apr;42(4):623-33. doi: 10.1007/s00259-014-2973-6. Epub 2015 Jan 9.
3
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
J Clin Oncol. 2014 Sep 20;32(27):3048-58. doi: 10.1200/JCO.2013.53.5229.
4
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
J Clin Oncol. 2014 Sep 20;32(27):3059-68. doi: 10.1200/JCO.2013.54.8800.
5
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma.
J Clin Oncol. 2014 Sep 1;32(25):2705-11. doi: 10.1200/JCO.2013.53.2838. Epub 2014 Jul 28.
6
Baseline metabolic tumour volume in Hodgkin lymphoma: the prognostic value of accessory cells.
Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1732-4. doi: 10.1007/s00259-014-2815-6.
7
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma.
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2017-22. doi: 10.1007/s00259-014-2822-7. Epub 2014 Jun 6.
8
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma.
Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1735-43. doi: 10.1007/s00259-014-2783-x. Epub 2014 May 9.
9
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
J Clin Oncol. 2014 Jun 10;32(17):1776-81. doi: 10.1200/JCO.2013.53.2507. Epub 2014 May 5.
10
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.
Haematologica. 2014 Jun;99(6):1107-13. doi: 10.3324/haematol.2013.103218. Epub 2014 Mar 21.
Zotero 插件